Global Computer Aided Diagnostics (CADx) Market - Analysis and Forecast (2017-2025)

Report Description

The computer aided diagnostics (CAD) have emerged as one of the major potential tools in the medical imaging and diagnostic radiology. The performance and interpretation of diagnostic radiology test is a complex process, since handling and interpretation of the large volume of medical data and images can lead to increasing chances of interpretation errors by the radiologists. However, the solution to the prevention of these errors is the usage of computer aided diagnostics (CAD), along with several imaging modalities, in order to analyse and interpret medical images more accurately and precisely. The primary factors associated with the usage of CAD solutions are decreased false negative rate, accurate detection of cancer at an early stage, increased specificity and sensitivity of the diagnostics tests, improved intra- and inter-reader variability and reduced mortality rates. 

This research study includes an extensive analysis of the global computer aided diagnostics (CAD) market, by application, diagnostics modalities and geographical regions, allowing the researcher to develop a comprehensive outlook of the market. Each of these segments has been analyzed on the basis of their current and future market size, considering the macro and micro environmental factors.

The market report presents a detailed and investigative study of the entire market and provides a comprehensive insight into various forms of developments, trends and key market participants. While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section on competitive landscape, market share analysis, competitive benchmarking, and the position of the competitors within the global computer aided diagnostics (CAD) market. 

The report includes the profiles of the major players in the market that allows the readers to get an insight into the various industry trends.  Some of the leading companies in the market are iCAD Inc., Hologic Inc., EDDA Technology, Inc., GE Healthcare, Merge Healthcare Inc., Siemens Healthcare, Agfa-Gevaert N.V., Fujifilm Medical Systems, Philips Healthcare, Samsung Medison, Neusoft Corporation, Invivo Corporation, Cadens Medical Imaging, Riverain technologies, Median Technologies and McKesson Corporation.

Key Questions Answered in this Report

The following key questions have been addressed in the report:

•  What are the major market drivers, challenges and opportunities of the global computer aided diagnostics market?
•  How the global computer aided diagnostics (CAD) market is evolving during the forecast period?
•  What are the driving and restraining factors in the global computer aided diagnostics (CAD) market?
•  What are the market shares of the leading segments and sub-segments of the global computer aided diagnostics (CAD) market in 2016 and 2025?
•  How will each segment of the computer aided diagnostics (CAD) market grow over the forecast period and how much revenue will these account for in 2025?
•  How will the market share of the leading companies change in 2017 and which country will lead the market in 2017?
•  How will the industry evolve during the forecast period between 2017 and 2025?
•  What are the key developmental strategies implemented in different types across all regions?
•  Which geographical region will lead the global computer aided diagnostics market by the end of the forecast period?
•  What are the market trends and key developments in this market?

Market Overview

With the advent of speech recognition software and computer aided diagnostics (CAD), the replacement of radiologists by computers has been swirling around for years. The introduction of deep learning and machine intelligence has re-ignited this discussion and the industry leaders are discussing what might happen in the upcoming 20 years. Handling and interpretation of large volume of medical data and images can lead to an increasing chances of errors by radiologist. Several tasks in radiology are extremely difficult, such as finding small lesions among several layers of fibro glandular breast tissues. The other tasks can be time consuming such as reviewing a large number of MRI or CT slices. However, the intent of CADx solutions is to aid the radiologists to perform the tasks more effectively and accurately with greater safety and speed.

The computer aided diagnostics (CAD) is a concept established by equally taking into account the roles of physicians and computers. It is based on computer algorithm (deep learning) which serves as “second reader” or “second opinion” in making the final decisions by the radiologists in the analytics and interpretations of huge collection of medical data. This technique of CADx helps the radiologists in accurately interpreting the images and identify the potential findings to avoid incorrect interpretations or overlooking of lesions. 

The rising incidence of various types of cancer such as breast, lung, prostate and colorectal, cancer is the primary responsible factor for the growth of CADx market. Furthermore, advancements in digital imaging techniques, improved efficiencies of CADx solutions, ease of integration of CADx solutions with various imaging equipment and growing awareness among the patients about early detection of cancer, have boosted the overall growth of this market. Moreover, the expansion of CADx applications to newer clinical areas, active research and development activities in medical imaging, rapid transition of hospitals to promote automatic workflow integration in their current work environment and rising installation base of CADx solutions in various multispecialty hospitals, is further expected to accentuate the growth of this market in the near future. However, certain restraining factors such as lack of adequate clinical data for validating the clinical efficacy of CADx solutions in its role of early diagnosis of the disease, disinclination of healthcare professionals in accepting these solutions as a standard imaging tool and premium pricing, might hamper the growth of this market. 

This research study includes an extensive analysis of the global computer aided diagnostics (CAD) market, by application, diagnostics modalities and geographical regions, allowing the researcher to develop a comprehensive outlook of the market. Each of these segments has been analyzed on the basis of their current and future market size, considering the macro and micro environmental factors.

The global computer aided diagnostics market is forecast to reach $XX million by 2025. The CADx market broadly focuses on major application areas (oncology, cardiovascular, and neurological) and various imaging modalities (mammography, MRI, tomosynthesis, etc.). The application segment of this market comprise of oncology and other diseases (neurological, cardiovascular and musculoskeletal) application areas. The oncology segment is further sub-segmented into breast, lung, colorectal, prostate, liver and other cancer. The breast cancer acquired the highest market value of $XX million in 2016, growing at a CAGR of XX% and is anticipated to reach $XX million in 2025. However, prostate cancer is growing at the highest CAGR XX%. The reason for such a strong market share is attributed to the rising incidence of breast cancer. According to the World Cancer Research Fund International, breast cancer is the most common cancer in women worldwide, with nearly 1.7 million new cases diagnosed in 2012. Further, according to National Cancer Institute, it is estimated that there will be 252,710 new cases of female breast cancer and an estimated XX people will die of this disease in 2017.

The Imaging modalities segment of this market comprise of various imaging tools such as mammography, magnetic resonance imaging (MRI), ultrasound imaging, tomosynthesis, computed tomography (CT) and others. The mammography acquired the highest market value of $XX million in 2016, growing at a CAGR of XX% and is anticipated to reach $XX million in 2025. However, the tomosynthesis imaging modalities is growing at the highest CAGR of XX%. The reason for holding such a strong market share is attributed to the continuous advancement in various digital imaging techniques, especially in mammography, MRI, tomosynthesis and computed tomography (CT). 

The computer aided diagnostics market’s geographical segment comprise of North America (the U.S. and Canada), Europe (Germany, France, Italy, Spain, Poland, Netherlands, Switzerland, and Austria among others), Asia-Pacific (Japan, China, South Korea, Australia, and India among others) and RoW (Brazil, Russia and Middle East among others).  In the computer aided diagnostics market’s segment, North America dominated the market with the highest market value $XX million in 2016, growing at a CAGR of XX% and is anticipated to reach $XX million in 2025. However, the Asia-Pacific region is expected to grow at a highest CAGR of XX%. 

The key players in the global computer aided diagnostics (CAD) market are Hologic Corporation, GE Healthcare, Invivo Corporation, ICADx Inc., Cadens Imaging, Siemens Healthcare, EDDA Technology and Agfa-Gevaert group. The market players are getting into the strategies such as collaborations, partnership & joint ventures, business expansion & contracts, product launches & developments, patents approvals & certifications, and mergers & acquisitions among others. The growing research and development, investments to integrate CADx with 3D imaging, rising demand for automated image analysis techniques and growing impact of cloud based solutions, are predicted to emerge as the potential growth drivers for the computer aided diagnostics market in the near future.